Dashboard
1
High Management Efficiency with a high ROE of 22.81%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 49.83
3
Healthy long term growth as Net Sales has grown by an annual rate of 7.08%
4
Flat results in Dec 24
5
With ROE of 0.00%, it has a Fair valuation with a 2.70 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.12%
0%
0.12%
6 Months
-12.65%
0%
-12.65%
1 Year
3.69%
0%
3.69%
2 Years
-24.61%
0%
-24.61%
3 Years
-41.77%
0%
-41.77%
4 Years
-49.12%
0%
-49.12%
5 Years
-55.38%
0%
-55.38%
Equasens for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.08%
EBIT Growth (5y)
0.96%
EBIT to Interest (avg)
49.83
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.84
Tax Ratio
20.21%
Dividend Payout Ratio
51.86%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
27.43%
ROE (avg)
22.81%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
2.70
EV to EBIT
NA
EV to EBITDA
EV to Capital Employed
3.05
EV to Sales
10.83
PEG Ratio
NA
Dividend Yield
15.28%
ROCE (Latest)
ROE (Latest)
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
216.80
219.80
-1.36%
Operating Profit (PBDIT) excl Other Income
59.40
68.60
-13.41%
Interest
1.10
0.70
57.14%
Exceptional Items
-1.00
-0.90
-11.11%
Consolidate Net Profit
37.80
48.90
-22.70%
Operating Profit Margin (Excl OI)
205.90%
252.10%
-4.62%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -1.36% vs 2.66% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -22.70% vs 0.62% in Dec 2023
About Equasens 
Equasens
Software Products
Pharmagest Interactive SA is a France-based company that develops and integrates management software packages for drugstores. The Company is engaged in the computerization of pharmaceutical dispensaries. Its flagship product is Integrated Portal Management Software, which provides pharmacists with permanent and immediate access to a range of online services and is used for the distribution of information and promotions for pharmaceutical suppliers and for pharmaceutical laboratories. In addition, the Company is engaged in the provision of maintenance services, technologies to manage medication compliance, as well as e-business solutions. It operates through Noviatek, Sailendra, Multimeds, British Caremeds and Axigate, among others.
Company Coordinates 
Company Details
5 allee de Saint-Cloud, Bp 117 , VILLERS LES NANCY None : 54600
Registrar Details






